Search clinical trials for: Daratumumab/Lenalidomide/Dexamethasone until progression
Total 548 results
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Withdrawn
-
Paul Richardson, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsActive, not recruiting
-
Nantes University HospitalCompleted
-
PETHEMA FoundationCelgene Corporation; AmgenActive, not recruitingSmoldering Multiple MyelomaSpain
-
Nantes University HospitalCompleted
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic Disease | Neoplasm, Plasma CellGreece
-
TakedaActive, not recruiting
-
Dana-Farber Cancer InstituteTakeda; CelgeneActive, not recruitingSmoldering Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
Merck Sharp & Dohme LLCTerminated
-
University Hospital, ToulouseTakeda; CelgeneTerminated
-
Weill Medical College of Cornell UniversityPfizer; Celgene CorporationTerminatedMultiple MyelomaUnited States
-
Fondazione EMN Italy OnlusCompleted
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
King's College Hospital NHS TrustCompleted
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
University of MiamiAmgen; Janssen PharmaceuticalsRecruitingMultiple MyelomaUnited States, Sweden
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
Kite, A Gilead CompanyArcellx, Inc.Not yet recruiting
-
Emory UniversityNational Cancer Institute (NCI); Takeda; National Institutes of Health (NIH); Janssen...Active, not recruiting
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Puerto Rico
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
Fondazione EMN Italy OnlusActive, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; AmgenWithdrawn
-
Janssen-Cilag International NVCompletedMultiple MyelomaFrance, United Kingdom, Spain, Poland, Serbia, Turkey, Greece, Germany, Hungary, Lithuania
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple MyelomaUnited States, New Zealand
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Multiple Myeloma Research Consortium; Blood Cancer Research...CompletedSmoldering Multiple MyelomaUnited States
-
PETHEMA FoundationCelgene; Janssen-Cilag Ltd.; TFS Trial Form SupportCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
M.D. Anderson Cancer CenterJanssen Services, LLCCompleted
-
Hellenic Society of HematologySanofiNot yet recruitingNeoplasms | Neoplasms by Histologic Type | Hematologic Diseases | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Renal ImpairmentGreece
-
Mario BoccadoroActive, not recruiting
-
Merck Sharp & Dohme LLCCompletedRelapsed or Refractory Multiple Myeloma
-
National Cancer Institute (NCI)CompletedRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Laryngeal Squamous Cell... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
CelgeneWithdrawnMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Bristol-Myers SquibbJanssen, LPActive, not recruitingMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's LymphomaUnited States, Poland, Italy, Belgium, France, Greece
-
AmgenTerminated
-
M.D. Anderson Cancer CenterBristol-Myers SquibbWithdrawnMultiple Myeloma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Denmark, Czechia, Israel, Switzerland, Belgium, United Kingdom, Japan, Argentina, Sweden, Canada, Spain, Germany, Netherlands, France, Brazil, Greece, Poland, Ireland, Hungary, Portugal, Australia, F... and more
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbTerminatedMultiple MyelomaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Juan DuRecruitingMultiple MyelomaChina
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminated
-
The First Affiliated Hospital with Nanjing Medical...RecruitingNon Hodgkin Lymphoma | Diffuse Large B Cell LymphomaChina